Tandem Diabetes Care Inc
NASDAQ:TNDM

Watchlist Manager
Tandem Diabetes Care Inc Logo
Tandem Diabetes Care Inc
NASDAQ:TNDM
Watchlist
Price: 30.81 USD 0.23% Market Closed
Market Cap: 2B USD
Have any thoughts about
Tandem Diabetes Care Inc?
Write Note

Operating Margin
Tandem Diabetes Care Inc

-15.6%
Current
-13%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-15.6%
=
Operating Profit
-133.6m
/
Revenue
854.4m

Operating Margin Across Competitors

Country US
Market Cap 2B USD
Operating Margin
-16%
Country US
Market Cap 204.9B USD
Operating Margin
17%
Country US
Market Cap 195.2B USD
Operating Margin
26%
Country US
Market Cap 146.7B USD
Operating Margin
22%
Country US
Market Cap 132.6B USD
Operating Margin
18%
Country IE
Market Cap 110.6B USD
Operating Margin
19%
Country US
Market Cap 64.7B USD
Operating Margin
14%
Country DE
Market Cap 55.6B EUR
Operating Margin
12%
Country CN
Market Cap 319.2B CNY
Operating Margin
37%
Country US
Market Cap 41.6B USD
Operating Margin
28%
Country US
Market Cap 37.7B USD
Operating Margin
13%
No Stocks Found

Tandem Diabetes Care Inc
Glance View

Market Cap
2B USD
Industry
Health Care

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company is headquartered in San Diego, California and currently employs 2,000 full-time employees. The company went IPO on 2013-11-13. The firm is focused on the design, development, and commercialization of technology solutions for people living with diabetes. The firm's manufacturing, sales, and support activities principally focus on its flagship pump platform, the t:slim X2, and its complementary product offerings. Its t:slim X2 is based on Company's technology platform and is the smallest durable insulin pump available in the United States. The firm has commercially offered two different automated insulin dosing (AID) algorithms on t:slim X2, including Control-IQ technology, which is an advanced hybrid-closed loop feature, designed to help increase a user's time in their targeted glycemic range, and Food and Drug Administration (FDA) to deliver automatic correction boluses in addition to adjusting insulin to help prevent high and low blood sugar based on continuous glucose monitoring (CGM) readings.

TNDM Intrinsic Value
45.81 USD
Undervaluation 33%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-15.6%
=
Operating Profit
-133.6m
/
Revenue
854.4m
What is the Operating Margin of Tandem Diabetes Care Inc?

Based on Tandem Diabetes Care Inc's most recent financial statements, the company has Operating Margin of -15.6%.